Naveen Kumar Chennamaneni

Second Generation Analogues of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery

James M. Kraus, Hari Babu Tatipaka, Sarah McGuffin et al. · Journal of Medicinal Chemistry · 2010 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI

Arun Kumar, Sophia Masi, Farideh Ghomashchi et al. · Clinical Chemistry · 2015 · 66 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI

Min-Ju Chan, Hsuan-Chieh Liao, Michael H. Gelb et al. · The Journal of Pediatrics · 2018 · 61 citations · Full text

Life Sciences, Biochemistry, Clinical Biochemistry +10

Pharmacological Characterization, Structural Studies, and <i>In Vivo</i> Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib

Frederick S. Buckner, Maria Terezinha Bahia, Praveen Kumar Suryadevara et al. · Antimicrobial Agents and Chemotherapy · 2012 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis

Liu Yang, Fan Yi, Arun Kumar et al. · Clinical Chemistry · 2017 · 50 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17